Contact –For more information about Xcelerate, Inc., check its EDGAR filings at: http://www.sec.gov/ or by calling Justin Baronoff 561-750-9800; . This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s registration statement and reports filed with the SEC. The Company claims the safe harbor provided by Section 21E(c) of the Exchange Act for all forward-looking statements. SOURCE Xcelerate, Inc.
Xcelerate has assembled an internationally recognized team of translational clinicians and engineers to identify and acquire engineering advancements and intellectual property that does not have immediately obvious applications to medical technology and clinical care. Xcelerate acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. ABOUT THE COMPANY
SAFE HARBOR AND INFORMATIONAL STATEMENT The Company’s chairman and chief executive officer, Michael O’Shea, said, “We are exceedingly pleased to establish this relationship with such a prestigious firm, which validates our business plan. We expect the assistance of this well-established investment banker will accelerate our growth. We have launched an aggressive acquisition program and have begun due diligence on several acquisition targets. Our management believes we can satisfy the conditions in our investment banking agreement.”
The News Highlights
- Xcelerate, Inc. Announces Investment Bank Agreements for Advisory Services and Acquisition Financing
- Check the latest News news updates and information about business, finance and more.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week